Better Therapeutics Inc. (BTTX)

0.00

-0.00 (-100.00%)

At close: Mar 03, 2025, 2:11 PM

0.01

3600.00%

Pre-market: Jun 20, 2024, 09:30 AM EDT

Better Therapeutics Cash Flow Statement

Table Mode

Year	FY22	FY21	FY20	FY19
Net Income	-39.76M	-40.34M	-6.39M	-5.78M
Depreciation & Amortization	2.73M	1.62M	75K	72K
Stock-Based Compensation	1.82M	646K	233K	84K
Other Working Capital	4.76M	-3.35M	125K	-521K
Other Non-Cash Items	9K	9.74M	-153K	-505
Deferred Income Tax	n/a	-152K	152K	505.00
Change in Working Capital	6.27M	-2.34M	306K	-589K
Operating Cash Flow	-28.93M	-30.82M	-5.77M	-6.22M
Capital Expenditures	-1.18M	-1.07M	-2.31M	-2.74M
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	-1.07M	-1.02K	-2.29K	-2.69K
Investing Cash Flow	-1.18M	-1.07M	-2.31M	-2.74M
Debt Repayment	5M	28.68M	n/a	5M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	284K	43.66M	7.45M	3.7M
Financial Cash Flow	5.28M	72.33K	7.45M	8.7M
Net Cash Flow	-24.83M	40.44M	-634K	-253K
Free Cash Flow	-30.11M	-31.89M	-8.08M	-8.95M